The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 20, Issue 11, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-24
DOI
10.1007/s11912-018-0732-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
- (2018) Mingjie Dong et al. Cell Death & Disease
- High response rate to PD-1 blockade in desmoplastic melanomas
- (2018) Zeynep Eroglu et al. NATURE
- Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014
- (2017) Joanne F. Aitken et al. INTERNATIONAL JOURNAL OF CANCER
- An age-dependent interaction between sex and geographical UV index in melanoma risk
- (2017) Feng Liu-Smith et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure
- (2017) Feng Liu-Smith et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
- (2017) Reinhard Dummer et al. LANCET ONCOLOGY
- Malignant Melanoma in African–Americans
- (2017) Krishnaraj Mahendraraj et al. MEDICINE
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
- (2017) Jeffrey Weber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melanocytic nevi and melanoma: unraveling a complex relationship
- (2017) W E Damsky et al. ONCOGENE
- Epigenetics of malignant melanoma
- (2017) Bruce Moran et al. SEMINARS IN CANCER BIOLOGY
- NRAS-mutant melanoma: current challenges and future prospect
- (2017) Eva Muñoz-Couselo et al. OncoTargets and Therapy
- Clinical Features Associated With Individuals at Higher Risk of Melanoma
- (2017) Caroline G. Watts et al. JAMA Dermatology
- Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype
- (2016) Leonardo S. Lino-Silva et al. ANNALS OF SURGICAL ONCOLOGY
- The role of mitogen-activated protein targeting in melanoma beyond BRAFV600
- (2016) Ryan J. Sullivan CURRENT OPINION IN ONCOLOGY
- Survival of patients with advanced metastatic melanoma: The impact of novel therapies
- (2016) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031
- (2016) David C. Whiteman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
- (2016) F Stephen Hodi et al. LANCET ONCOLOGY
- Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
- (2016) Ximena Bonilla et al. NATURE GENETICS
- Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas
- (2016) Holger A. Haenssle et al. JAMA Dermatology
- mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation
- (2015) William Damsky et al. CANCER CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Cell cycle control as a promising target in melanoma
- (2015) Belinda Lee et al. CURRENT OPINION IN ONCOLOGY
- The melanocyte lineage in development and disease
- (2015) R. L. Mort et al. DEVELOPMENT
- More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia
- (2015) David C. Whiteman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
- (2015) Michael Krauthammer et al. NATURE GENETICS
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas
- (2015) Jonathan J. Lee et al. Clinical Epigenetics
- Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
- (2014) Moriah H. Nissan et al. CANCER RESEARCH
- Understanding the Biology of Melanoma and Therapeutic Implications
- (2014) Ryan J. Sullivan et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis
- (2014) Sophia Colantonio et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis
- (2014) R.J.T. van der Leest et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- BRAF inhibitor activity in V600R metastatic melanoma – Response
- (2013) Oliver Klein et al. EUROPEAN JOURNAL OF CANCER
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- UV Radiation and the Skin
- (2013) John D'Orazio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
- (2013) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
- (2013) Arjen Joosse et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma Epidemic: An Analysis of Six Decades of Data From the Connecticut Tumor Registry
- (2013) Alan C. Geller et al. JOURNAL OF CLINICAL ONCOLOGY
- MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
- (2013) Paolo A Ascierto et al. LANCET ONCOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Deciphering Signatures of Mutational Processes Operative in Human Cancer
- (2013) Ludmil B. Alexandrov et al. Cell Reports
- Legislation Restricting Access to Indoor Tanning Throughout the World
- (2012) Mary T. Pawlak et al. ARCHIVES OF DERMATOLOGY
- Melanoma incidence and mortality in Europe: new estimates, persistent disparities
- (2012) A.M. Forsea et al. BRITISH JOURNAL OF DERMATOLOGY
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- A potential role for nilotinib inKIT-mutated melanoma
- (2012) An Tran et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Melanoma in Immunosuppressed Patients
- (2012) Agnieszka W. Kubica et al. MAYO CLINIC PROCEEDINGS
- Melanoma genome sequencing reveals frequent PREX2 mutations
- (2012) Michael F. Berger et al. NATURE
- MAP kinase signaling and inhibition in melanoma
- (2012) R J Sullivan et al. ONCOGENE
- A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important
- (2012) Feng Liu et al. Pigment Cell & Melanoma Research
- BRAF L597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors
- (2012) Kimberly Brown Dahlman et al. Cancer Discovery
- Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006
- (2011) Peter Baade et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboringc-KitMutation or Amplification
- (2011) Jun Guo et al. JOURNAL OF CLINICAL ONCOLOGY
- The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin
- (2011) David C. Whiteman et al. Pigment Cell & Melanoma Research
- Melanoma Thickness Trends in the United States, 1988–2006
- (2009) Vincent D. Criscione et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search